Status:

ACTIVE_NOT_RECRUITING

Prairie Loin Pain Hematuria Syndrome Renal Denervation Study: A Feasibility Study

Lead Sponsor:

Saskatchewan Health Authority - Regina Area

Collaborating Sponsors:

University of Saskatchewan

Conditions:

Loin Pain-Hematuria Syndrome

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Loin Pain Hematuria Syndrome (LPHS) is a poorly understood, painful and incapacitating condition that typically afflicts young women and was first described in 1967. Currently, the treatment for LPHS ...

Detailed Description

Research Design and Methods This study is a double-blinded, parallel group, sham-controlled, randomized control, partial crossover feasibility trial. This feasibility trial is a part of a larger clin...

Eligibility Criteria

Inclusion

  • Inclusion/ Exclusion Criteria
  • Inclusion criteria for patients to be invited to participate in the study are:
  • ≥ 18 years of age
  • Diagnosed with loin pain hematuria syndrome by a nephrologist, in consultation with a urologist.
  • Current use of prescription pain medication for LPHS treatment
  • Arteries with a diameter between 3 mm and 8 mm.
  • Exclusion criteria for patients to be screened out of the study are:
  • History of kidney auto transplantation
  • Estimated glomerular filtration rate (eGFR) \<45 mL/min/1.73m2
  • Pregnant or nursing
  • Need chronic oxygen support or mechanical ventilation via tracheostomy continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP)
  • Renovascular abnormalities
  • Prior renal angioplasty, indwelling renal stents and/or aortic stent grafts
  • Evidence of a somatoform disorder as per the SCID-5
  • Unavailable to travel to Regina, SK one day prior to the procedure to meet with the Principal Investigator and study coordinator

Exclusion

    Key Trial Info

    Start Date :

    December 1 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2024

    Estimated Enrollment :

    10 Patients enrolled

    Trial Details

    Trial ID

    NCT04332731

    Start Date

    December 1 2020

    End Date

    December 31 2024

    Last Update

    April 16 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Saskatchewan Health Authority

    Regina, Saskatchewan, Canada